Protective effect of clodronate-containing liposomes on intestinal mucosal injury in rats with severe acute pancreatitis

Hepatobiliary and Pancreatic Diseases International

Volumn 10, Issue 5, 2011, Pages 544-551

  Zhang, Jian Xin ^a   Dang, Sheng Chun ^a   Yin, Kai ^a   Jiang, De Li ^b  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Clodronate disodium; Intestinal mucosal injury; Macrophage; Pancreatitis

Indexed keywords

CD68 ANTIGEN; CLODRONIC ACID; EOSIN; HEMATOXYLIN; INTERLEUKIN 12; LIPOSOME; PHOSPHATE BUFFERED SALINE; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; FEMALE; IMMUNOHISTOCHEMISTRY; INTESTINE; INTESTINE INJURY; MACROPHAGE; NICK END LABELING; NONHUMAN; PANCREAS; RAT; SCORING SYSTEM; SUPERIOR MESENTERIC VEIN;

EID: 80053213552     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(11)60092-1     Document Type: Article

References (33)

1. Glisić T, Sijacki A, Vuković V, Subotić A. Bernard Organ Failure Score in estimation of most severe forms of acute pancreatitis. Srp Arh Celok Lek 2009;137:166-170.
2. Singh VK, Wu BU, Bollen TL, Repas K, Maurer R, Mortele KJ, et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis. Clin Gastroenterol Hepatol 2009;7:1247-1251.
3. Ammori BJ. Gut barrier dysfunction in patients with acute pancreatitis. J Hepatobiliary Pancreat Surg 2002;9:411-412.
4. Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg 2003;7: 26-36.
5. Zhang XP, Zhang J, Song QL, Chen HQ. Mechanism of acute pancreatitis complicated with injury of intestinal mucosa barrier. J Zhejiang Univ Sci B 2007;8:888-895.
6. Jha RK, Yong MQ, Chen SH. The protective effect of resveratrol on the intestinal mucosal barrier in rats with severe acute pancreatitis. Med Sci Monit 2008;14:BR14-19.
7. Mikami Y, Takeda K, Shibuya K, Qiu-Feng H, Shimamura H, Yamauchi J, et al. Do peritoneal macrophages play an essential role in the progression of acute pancreatitis in rats? Pancreas 2003;27:253-260.
8. Wereszczynska-Siemiatkowska U, Dlugosz JW, Siemiatkowski A, Chyczewski L, Gabryelewicz A. Lysosomal activity of pulmonary alveolar macrophages in acute experimental pancreatitis in rats with reference to positive PAF-antagonist (BN 52021) effect. Exp Toxicol Pathol 2000;52:119-125.
9. Gutierrez PT, Folch-Puy E, Bulbena O, Closa D. Oxidised lipids present in ascitic fluid interfere with the regulation of the macrophages during acute pancreatitis, promoting an exacerbation of the inflammatory response. Gut 2008;57:642-648.
10. Berardi D, Raffaelli L, Perfetti G, Paolantonio M, Trisi P. Clodronate combined with a surfactant (Tween 20) does not improve osseointegration: a rabbit immunohistomorphometric study. Int J Immunopathol Pharmacol 2009;22:829-835.
11. Kitamoto K, Machida Y, Uchida J, Izumi Y, Shiota M, Nakao T, et al. Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. J Pharmacol Sci 2009;111:285-292.
12. Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25:97-106.
13. van Rooijen N, van Kesteren-Hendrikx E. In vivo depletion of macrophages by liposome-mediated suicide. Methods Enzymol 2003;373:3-16.
14. Brigham DE, Little G, Lukyanenko YO, Hutson JC. Effects of clodronate-containing liposomes on testicular macrophages and Leydig cells in vitro. J Endocrinol 1997;155:87-92.
15. Zhang JX, Dang SC, Qu JG, Wang XQ. Preventive effect of tetramethylpyrazine on intestinal mucosal injury in rats with acute necrotizing pancreatitis. World J Gastroenterol 2006;12:6386-6390.
16. Kaiser AM, Saluja AK, Sengupta A, Saluja M, Steer ML. Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am J Physiol 1995;269:C1295-1304.
17. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101:478-483.
18. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas 2003;26:122-129.
19. Lankisch PG, Lerch MM. Pharmacological prevention and treatment of acute pancreatitis: where are we now? Dig Dis 2006;24:148-159.
20. Sakorafas GH, Tsiotou AG. Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 2000;30:343-356.
21. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002;9:401-410.
22. Rychter JW, van Minnen LP, Verheem A, Timmerman HM, Rijkers GT, Schipper ME, et al. Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis. Surgery 2009;145:157-167.
23. Nagpal K, Minocha VR, Agrawal V, Kapur S. Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis. Am J Surg 2006;192:24-28.
24. Juvonen PO, Alhava EM, Takala JA. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol 2000; 35:1314-1318.
25. Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986;91:433-438.
26. Rahman SH, Ammori BJ, Larvin M, McMahon MJ. Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response? Gut 2003;52:270-274.
27. Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 2009;28:2114-2127.
28. van Rooijen N, Sanders A, van den Berg TK. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods 1996;193:93-99.
29. Roelofs AJ, Thompson K, Gordon S, Rogers MJ. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 2006;12:6222s-6230s.
30. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000;88:2961-2978.
31. Mönkkönen J, Taskinen M, Auriola SO, Urtti A. Growth inhibition of macrophage-like and other cell types by liposomeencapsulated, calcium-bound, and free bisphosphonates in vitro. J Drug Target 1994;2:299-308.
32. Frith JC, Mönkkönen J, Blackburn GM, Russell RG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 1997;12:1358-1367.
33. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.